Folfirinox-Bevacizumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of fluorouracil, leucovorin, oxaliplatin and irinotecan (FOLFIRINOX), and bevacizumab that may be used for the treatment of ampullary, appendiceal and small bowel adenocarcinomas, and colorectal cancer.

**Synonyms:** - Bevacizumab Plus Folfirinox - Bevacizumab-Folfirinox - FOLFIRINOX and Bevacizumab - FOLFIRINOX and Bevacizumab (L-Leucovorin) - FOLFIRINOX and Bevacizumab-adcd - FOLFIRINOX and Bevacizumab-adcd (L-Leucovorin) - FOLFIRINOX and Bevacizumab-awwb - FOLFIRINOX and Bevacizumab-awwb (L-Leucovorin) - FOLFIRINOX and Bevacizumab-aybi - FOLFIRINOX and Bevacizumab-aybi (L-Leucovorin) - FOLFIRINOX and Bevacizumab-bvzr - FOLFIRINOX and Bevacizumab-bvzr (L-Leucovorin) - FOLFIRINOX and Bevacizumab-equi - FOLFIRINOX and Bevacizumab-equi (L-Leucovorin) - FOLFIRINOX and Bevacizumab-maly - FOLFIRINOX and Bevacizumab-maly (L-Leucovorin) - FOLFIRINOX and Bevacizumab-onbe - FOLFIRINOX and Bevacizumab-onbe (L-Leucovorin) - FOLFIRINOX and Bevacizumab-tnjn - FOLFIRINOX and Bevacizumab-tnjn (L-Leucovorin) - Folfirinox Plus Bevacizumab - Folfirinox-Avastin - Folfirinox-Bevacizumab - Folfirinox/Bevacizumab